BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 5, 2010
View Archived Issues
Cediranib shows potential to treat epithelial ovarian, fallopian tube and peritoneal cancer
Read More
European Commission approves Pfizer's Revatio injection for pulmonary arterial hypertension
Read More
Ark Therapeutics files request with EMEA for re-examination of MAA for Cerepro
Read More
Boston Scientific initiates enrollment into postapproval study of Taxus Liberte stent
Read More
Data reported from three phase II studies of BIBW-2992 in metastatic breast cancer
Read More
PEG 15-20 to enter clinical trial after shown to protect rodent intestine from radiation
Read More
DAPH-12 and epigallocatechin gallate synergize to inhibit prion strains
Read More
8-Chloro-adenosine to be investigated in patients with breast cancer
Read More
BioInvent initiates treatment in phase I trial of BI-505 antibody for multiple myeloma
Read More
BioForm Medical to be acquired by Merz and renamed Merz Aesthetics
Read More
Dynavax Technologies acquires Symphony Dynamo
Read More
Dainippon Sumitomo submits NDA to FDA for lurasidone in schizophrenia
Read More
FDA grants priority review to InterMune's NDA for pirfenidone for idiopathic pulmonary fibrosis
Read More
Adventrx submits NDA to FDA for ANX-530
Read More
Anterogen begins phase I trial of ANT-SM in fecal incontinence
Read More
Novo Nordisk initiates phase I trial of oral insulin analogue NN-1952
Read More
First-in-man study of EMD-1214063 initiated in patients with solid tumors
Read More
FDA approves Takeda's sNDA for Velcade for first-line treatment of multiple myeloma
Read More
Janssen discloses novel HDAC inhibitors for cancer treatment
Read More
Swiss scientists present novel BB2 antagonists for cancer diagnosis and treatment
Read More
Dr. Reddy's Laboratories and Nordic Bioscience report results from phase III balaglitazone trial
Read More
MethylGene describes tyrosine kinase inhibitors for the treatment of proliferative diseases
Read More
Janssen presents protein kinase inhibitors for cancer therapy
Read More
Chinese scientists describe novel compounds for cancer treatment
Read More
NeoPharm files IND with FDA for phase I trial of IL-13-PE38QQR in idiopathic pulmonary fibrosis
Read More